Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected RecipientsChristine M. Durand, Niraj M. Desai, Mary G. Bowring et al.|Annals of Internal Medicine|2018Cited by 295
The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United StatesChristine M. Durand, Dorry L. Segev, Alvin G. Thomas et al.|Annals of Internal Medicine|2018Cited by 195
A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in actionChristine M. Durand, Dorry L. Segev, Wanying Zhang et al.|American Journal of Transplantation|2020Cited by 112
Characterizing the landscape and impact of infections following kidney transplantationKyle R. Jackson, Jennifer D. Motter, Sunjae Bae et al.|American Journal of Transplantation|2020Cited by 63
Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning studyAllan B. Massie, Brian J. Boyarsky, William A. Werbel et al.|American Journal of Transplantation|2020Cited by 59